Pill Form of Semaglutide Fails to Slow Alzheimer’s in Large Trial
TUESDAY, Nov. 25, 2025 (HealthDay News) — A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer’s disease, drugmaker Novo Nordisk announced Monday. In two Phase 3 trials, researchers tested an oral form of semaglutide in more than 3,800 adults with Alzheimer’sContinue Reading













-690x550.jpg)
